{"id":"https://openalex.org/W3152962329","doi":"https://doi.org/10.1080/14712598.2021.1921140","title":"Combining anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) and -programmed cell death protein 1 (PD-1) agents for cancer immunotherapy","display_name":"Combining anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) and -programmed cell death protein 1 (PD-1) agents for cancer immunotherapy","publication_year":2021,"publication_date":"2021-04-23","ids":{"openalex":"https://openalex.org/W3152962329","doi":"https://doi.org/10.1080/14712598.2021.1921140","mag":"3152962329","pmid":"https://pubmed.ncbi.nlm.nih.gov/33890832","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13093870"},"language":"en","primary_location":{"id":"doi:10.1080/14712598.2021.1921140","doi":"https://doi.org/10.1080/14712598.2021.1921140","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14712598.2021.1921140","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13093870/pdf/nihms-2161900.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087049625","display_name":"Selina K. Wong","orcid":"https://orcid.org/0000-0001-8420-2678","observed_orcids":["https://orcid.org/0000-0001-8420-2678"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Selina K. Wong","raw_affiliation_strings":["Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074077037","display_name":"Kathryn Eby Beckermann","orcid":"https://orcid.org/0000-0002-4616-6140","observed_orcids":["https://orcid.org/0000-0002-4616-6140"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathryn E. Beckermann","raw_affiliation_strings":["Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025067315","display_name":"Douglas Buckner Johnson","orcid":"https://orcid.org/0000-0002-6390-773X","observed_orcids":["https://orcid.org/0000-0002-6390-773X"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Douglas B. Johnson","raw_affiliation_strings":["Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066217699","display_name":"Satya Das","orcid":"https://orcid.org/0000-0002-7625-1039","observed_orcids":["https://orcid.org/0000-0002-7625-1039"]},"institutions":[{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Satya Das","raw_affiliation_strings":["Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Hematology & Oncology, Vanderbilt University Medical Center, Nashville, TN, USA","institution_ids":["https://openalex.org/I901861585"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5066217699"],"corresponding_institution_ids":["https://openalex.org/I901861585"],"apc_list":null,"apc_paid":null,"fwci":1.2739,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":{"value":0.831532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"21","issue":"12","first_page":"1623","last_page":"1634"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.871999979019165},{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":1.0},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8700000047683716},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.9539999961853027},{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8970000147819519},{"id":"https://openalex.org/keywords/treatment-schedule","display_name":"treatment schedule","score":0.6269999742507935},{"id":"https://openalex.org/keywords/toxicity-profile","display_name":"toxicity profile","score":0.6380000114440918},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.6549999713897705},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.47099998593330383}],"concepts":[{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.7236641645431519},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6642524003982544},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.64482182264328},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6165201663970947},{"id":"https://openalex.org/C2781433595","wikidata":"https://www.wikidata.org/wiki/Q2459042","display_name":"Ipilimumab","level":4,"score":0.5957707166671753},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5703813433647156},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.568914532661438},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5619394183158875},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.49923205375671387},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4513798952102661},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.44947192072868347},{"id":"https://openalex.org/C45121317","wikidata":"https://www.wikidata.org/wiki/Q4927287","display_name":"Blocking antibody","level":3,"score":0.4430200457572937},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.4306853413581848},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.330752968788147},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32502347230911255},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19123134016990662},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1517036259174347},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06361508369445801},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1080/14712598.2021.1921140","doi":"https://doi.org/10.1080/14712598.2021.1921140","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14712598.2021.1921140","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13093870","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13093870/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13093870/pdf/nihms-2161900.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opin Biol Ther","raw_type":"Text"},{"id":"pmid:33890832","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33890832","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on biological therapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:13093870","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13093870/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13093870/pdf/nihms-2161900.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opin Biol Ther","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000083166","display_name":"Vanderbilt Clinical Oncology Research Career Development Award","funder_award_id":"K12CA090625","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320312140","display_name":"Exelixis","ror":"https://ror.org/01e3jga91"},{"id":"https://openalex.org/F4320317544","display_name":"Incyte","ror":"https://ror.org/00cvzzg84"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3152962329.pdf","grobid_xml":"https://content.openalex.org/works/W3152962329.grobid-xml"},"referenced_works_count":88,"referenced_works":["https://openalex.org/W1538902372","https://openalex.org/W1940241680","https://openalex.org/W1992450231","https://openalex.org/W2015085911","https://openalex.org/W2040956995","https://openalex.org/W2048073154","https://openalex.org/W2056535502","https://openalex.org/W2063264144","https://openalex.org/W2076067786","https://openalex.org/W2094366129","https://openalex.org/W2099560139","https://openalex.org/W2099752220","https://openalex.org/W2104327407","https://openalex.org/W2107752337","https://openalex.org/W2112601576","https://openalex.org/W2115623838","https://openalex.org/W2118471749","https://openalex.org/W2124505866","https://openalex.org/W2128035403","https://openalex.org/W2128758225","https://openalex.org/W2143163879","https://openalex.org/W2222086386","https://openalex.org/W2285168390","https://openalex.org/W2529484692","https://openalex.org/W2547133566","https://openalex.org/W2554479252","https://openalex.org/W2560704457","https://openalex.org/W2606367731","https://openalex.org/W2622499649","https://openalex.org/W2724506765","https://openalex.org/W2739132742","https://openalex.org/W2753432434","https://openalex.org/W2760942750","https://openalex.org/W2763064222","https://openalex.org/W2768429453","https://openalex.org/W2782007611","https://openalex.org/W2783137027","https://openalex.org/W2784868445","https://openalex.org/W2786816161","https://openalex.org/W2789732304","https://openalex.org/W2792937256","https://openalex.org/W2793364080","https://openalex.org/W2797675588","https://openalex.org/W2801062708","https://openalex.org/W2803558333","https://openalex.org/W2808750176","https://openalex.org/W2888298425","https://openalex.org/W2888599070","https://openalex.org/W2891486030","https://openalex.org/W2895125473","https://openalex.org/W2898303823","https://openalex.org/W2898631010","https://openalex.org/W2908887190","https://openalex.org/W2909056931","https://openalex.org/W2909198142","https://openalex.org/W2915708315","https://openalex.org/W2916451481","https://openalex.org/W2917423789","https://openalex.org/W2950056455","https://openalex.org/W2964133630","https://openalex.org/W2971944400","https://openalex.org/W2976744492","https://openalex.org/W2990602950","https://openalex.org/W2998924590","https://openalex.org/W3002637272","https://openalex.org/W3002973089","https://openalex.org/W3005328351","https://openalex.org/W3005693093","https://openalex.org/W3009244677","https://openalex.org/W3009875356","https://openalex.org/W3011071920","https://openalex.org/W3016210953","https://openalex.org/W3021442601","https://openalex.org/W3025022288","https://openalex.org/W3028638056","https://openalex.org/W3028977302","https://openalex.org/W3029462827","https://openalex.org/W3029560938","https://openalex.org/W3029572589","https://openalex.org/W3032064298","https://openalex.org/W3032226134","https://openalex.org/W3032544449","https://openalex.org/W3035208766","https://openalex.org/W3043703771","https://openalex.org/W3085224821","https://openalex.org/W3090413519","https://openalex.org/W3105455308","https://openalex.org/W3127379102"],"related_works":["https://openalex.org/W2975608733","https://openalex.org/W2952065098","https://openalex.org/W3124047768","https://openalex.org/W3110504752","https://openalex.org/W3028301539","https://openalex.org/W2096322385","https://openalex.org/W4372342026","https://openalex.org/W4322763683","https://openalex.org/W2530004119","https://openalex.org/W3186656946"],"abstract_inverted_index":{"Introduction:":[0],"Cytotoxic":[1],"T-lymphocyte":[2],"antigen":[3],"4":[4],"(CTLA-4)":[5],"and":[6,107,124,152,176],"programmed":[7],"cell":[8],"death":[9],"protein":[10],"1":[11],"(PD-1)":[12],"represent":[13],"inhibitory":[14],"immune":[15,18],"checkpoints.":[16],"Combination":[17],"checkpoint":[19],"inhibitor":[20],"(ICI)":[21],"therapy":[22,36,135],"with":[23,37,60,104,136,148,171],"anti-CTLA-4":[24,46,72,98,137,175,193],"plus":[25,47,73,99,138],"anti-PD-1":[26,48,74,100,139,180],"antibodies":[27,49,101,140],"in":[28,54,88,102,187],"preclinical":[29],"models":[30],"demonstrated":[31],"greater":[32],"anti-tumor":[33,44],"effect":[34],"than":[35],"either":[38],"antibody":[39],"alone.":[40],"Based":[41],"upon":[42],"this":[43],"effect,":[45],"have":[50],"since":[51],"been":[52],"tested":[53],"a":[55,143,189],"patients,":[56],"across":[57],"tumor":[58],"types,":[59],"advanced":[61,105],"malignancies.Areas":[62],"covered:":[63],"Herein":[64],"we":[65,163],"describe":[66],"the":[67,76,85,90,95,108,160],"biologic":[68],"rationale":[69],"for":[70,97,146],"combining":[71],"antibodies,":[75,181],"early":[77],"studies":[78,92],"which":[79,93,188],"established":[80,94],"different":[81],"treatment":[82,144],"schedules":[83],"of":[84,111,174,179,192],"ICI":[86,157],"combination":[87,134],"melanoma,":[89],"definitive":[91],"role":[96],"patients":[103,147,167],"malignancies":[106],"toxicity":[109,161],"profiles":[110],"these":[112],"agents.":[113],"We":[114,131],"also":[115],"discuss":[116],"several":[117],"experimental":[118],"disease":[119],"settings":[120],"where":[121],"combined":[122],"CTLA-4":[123],"PD-1":[125],"blockade":[126],"is":[127,194],"being":[128],"explored.Expert":[129],"opinion:":[130],"anticipate":[132],"that":[133,165],"will":[141,168],"become":[142],"standard":[145],"cancers":[149],"both":[150],"responsive":[151],"unresponsive":[153],"to":[154],"single":[155],"agent":[156],"therapy.":[158],"Given":[159],"profile,":[162],"expect":[164],"most":[166],"be":[169,185],"treated":[170],"lower":[172],"doses":[173,178],"full":[177],"however,":[182],"there":[183],"may":[184],"instances":[186],"higher":[190],"dose":[191],"preferred.":[195]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-04-26T00:00:00"}